The ADHD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADHD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ADHD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ADHD Detailed Price Forecast - CNN Money||View ADHD Detailed Summary - Google Finance|
|View ADHD Detailed Summary - Yahoo! Finance||View ADHD Stock Research & Analysis - Zacks.com|
|View ADHD Trends & Analysis - Trade-Ideas||View ADHD Major Holders - Barrons|
|View ADHD Call Transcripts - NASDAQ||View ADHD Breaking News & Analysis - Seeking Alpha|
|View ADHD Annual Report - CompanySpotlight.com||View ADHD OTC Short Report - OTCShortReport.com|
|View ADHD Fundamentals - TradeKing||View ADHD SEC Filings - Bar Chart|
|View Historical Prices for ADHD - The WSJ||View Performance/Total Return for ADHD - Morningstar|
|View the Analyst Estimates for ADHD - MarketWatch||View the Earnings History for ADHD - CNBC|
|View the ADHD Earnings - StockMarketWatch||View ADHD Buy or Sell Recommendations - MacroAxis|
|View the ADHD Bullish Patterns - American Bulls||View ADHD Short Pain Metrics - ShortPainBot.com|
|View ADHD Stock Mentions - StockTwits||View ADHD Stock Mentions - PennyStockTweets|
|View ADHD Stock Mentions - Twitter||View ADHD Investment Forum News - Investor Hub|
|View ADHD Stock Mentions - Yahoo! Message Board||View ADHD Stock Mentions - Seeking Alpha|
|View Insider Transactions for ADHD - SECform4.com||View Insider Transactions for ADHD - Insider Cow|
|View ADHD Major Holdings Summary - CNBC||View Insider Disclosure for ADHD - OTC Markets|
|View Insider Transactions for ADHD - Yahoo! Finance||View Institutional Holdings for ADHD - NASDAQ|
|View ADHD Stock Insight & Charts - FinViz.com||View ADHD Investment Charts - StockCharts.com|
|View ADHD Stock Overview & Charts - BarChart||View ADHD User Generated Charts - Trading View|
Alcobra reports 3Q loss
Posted on Thursday November 09, 2017
On a per-share basis, the Tel Aviv, Israel-based company said it had a loss of 9 cents. The company's shares closed at $1.35. A year ago, they were trading at $1.91. _____ This story was generated by Automated ...
Arcturus Therapeutics and Synthetic Genomics Announce Strategic Alliance to Develop Next-Generation Vaccines and Therapeutics
Posted on Tuesday October 31, 2017
SAN DIEGO, Oct. 31, 2017 /PRNewswire/ -- Arcturus Therapeutics, Inc., a leading RNA medicines company, and Synthetic Genomics, Inc. announced today that they have entered into a research collaboration and worldwide license agreement to develop self-amplifying RNA-based vaccines and therapeutics in both human and animal health. The collaboration will bring together Arcturus's LUNAR™ lipid-mediated delivery platform with Synthetic Genomics' RNA replicon platform to potentially enable more efficacious and lower cost vaccines and therapeutics.
Today's Research Reports on Stocks to Watch: Alcobra and Imprimis Pharmaceuticals
Posted on Friday October 20, 2017
NEW YORK, NY / ACCESSWIRE / October 20, 2017 / Alcobra headed higher on Thursday after the company's wholly-owned subsidiary Arcturus entered into a research collaboration and worldwide license agreement ...
Alcobra Ltd (ADHD) Stock Fires Up To The Roof; Here’s Why
Posted on Thursday October 19, 2017
Alcobra Ltd (NASDAQ:ADHD) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 40% upturn. Alcobra's wholly-owned subsidiary, Arcturus, announced that it has entered into a research collaboration and worldwide license agreement with Janssen Pharmaceuticals - a subsidiary of Johnson & Johnson. According to the agreement, the two companies will work together to develop and commercialize nucleic acid-based drug products for the treatment of Hepatitis B, using Arcturus’ UNA Oligomer chemistry and LUNAR™ lipid-mediated delivery platform.